JP2008528480A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528480A5
JP2008528480A5 JP2007551814A JP2007551814A JP2008528480A5 JP 2008528480 A5 JP2008528480 A5 JP 2008528480A5 JP 2007551814 A JP2007551814 A JP 2007551814A JP 2007551814 A JP2007551814 A JP 2007551814A JP 2008528480 A5 JP2008528480 A5 JP 2008528480A5
Authority
JP
Japan
Prior art keywords
amino acid
pharmaceutical composition
peptide
composition according
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007551814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008528480A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2006/000096 external-priority patent/WO2006077601A2/en
Publication of JP2008528480A publication Critical patent/JP2008528480A/ja
Publication of JP2008528480A5 publication Critical patent/JP2008528480A5/ja
Abandoned legal-status Critical Current

Links

JP2007551814A 2005-01-24 2006-01-24 免疫調節用ＨＩＶ−１ｇｐ４１融合ペプチド Abandoned JP2008528480A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64560505P 2005-01-24 2005-01-24
PCT/IL2006/000096 WO2006077601A2 (en) 2005-01-24 2006-01-24 HIV-1 gp41 FUSION PEPTIDES FOR IMMUNOMODULATION

Publications (2)

Publication Number Publication Date
JP2008528480A JP2008528480A (ja) 2008-07-31
JP2008528480A5 true JP2008528480A5 (https=) 2009-03-05

Family

ID=36692632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007551814A Abandoned JP2008528480A (ja) 2005-01-24 2006-01-24 免疫調節用ＨＩＶ−１ｇｐ４１融合ペプチド

Country Status (7)

Country Link
US (1) US20090270312A1 (https=)
EP (1) EP1843777A2 (https=)
JP (1) JP2008528480A (https=)
CN (1) CN101115498A (https=)
AU (1) AU2006207181A1 (https=)
CA (1) CA2595414A1 (https=)
WO (1) WO2006077601A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10138276B2 (en) 2009-09-30 2018-11-27 Signablok, Inc. Inhibition of TCR signaling with peptide variants
US8986712B2 (en) 2009-11-29 2015-03-24 Yeda Research And Development Co., Ltd. Peptides derived from HIV-1 gp41 transmembrane domain for t-immunomodulation
CN103732238A (zh) * 2011-06-08 2014-04-16 奥瑞基尼探索技术有限公司 用于免疫调节的治疗性化合物
WO2014002089A1 (en) * 2012-06-27 2014-01-03 Yeda Research And Development Co. Ltd. Peptides derived from hiv gp41 for treating t-cell mediated pathologies
AU2015325013B2 (en) 2014-10-01 2021-01-28 PI AgSciences Inc. Hypersensitive response elicitor peptides and use thereof
US10743538B2 (en) 2014-10-01 2020-08-18 Plant Health Care, Inc. Elicitor peptides having disrupted hypersensitive response box and use thereof
BR112018069945A2 (pt) 2016-04-06 2019-02-05 Plant Health Care, Inc. micróbios benéficos para distribuição de peptídeos ou proteínas efetoras e uso dos mesmos
ES3039620T3 (en) 2016-04-06 2025-10-23 Plant Health Care Inc Hypersensitive response elicitor-derived peptides and use thereof
WO2018037416A1 (en) * 2016-08-25 2018-03-01 Yeda Research And Development Co. Ltd. Methods and compositions for treating autoimmune diseases
US11602559B2 (en) 2016-10-03 2023-03-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HIV-1 Env fusion peptide immunogens and their use
KR20200049594A (ko) * 2018-10-24 2020-05-08 주식회사 툴젠 조작된 면역 세포

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230887A (en) * 1990-07-11 1993-07-27 Immune Network Research Ltd. Immune system stabilizers for prevention and therapy of disorders associated with immune system disfunction
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US6316420B1 (en) * 1998-07-28 2001-11-13 Technion Research And Development Foundation Ltd. DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis
US7410757B1 (en) * 1999-09-17 2008-08-12 Keio University Method of screening disease depressant gene
DE19957838C2 (de) * 1999-11-25 2002-11-21 Pette Heinrich Inst Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden
WO2005034842A2 (en) * 2003-05-19 2005-04-21 Progenics Pharmaceuticals, Inc. Peptides useful as hiv fusion inhibitors

Similar Documents

Publication Publication Date Title
JP7819087B2 (ja) インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
JP7170081B2 (ja) 新規なポリペプチド
US10745442B2 (en) Compstatin analogs with improved pharmacokinetic properties
RS66991B1 (sr) Peptidni inhibitori interleukin-23 receptora i njihova primena u lečenju inflamatornih bolesti
JP2023511551A (ja) インターロイキン２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
WO2021146458A1 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
WO2020014646A1 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
JP2008528480A5 (https=)
CA3146390A1 (en) Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
SG178721A1 (en) Amino acid prodrugs
WO2019080919A1 (zh) 充分剂量条件下治疗乙肝病毒相关肝病的药物和方法
US10632187B2 (en) Hemagglutinin-binding peptide
CA3210657A1 (en) Glucagon-like peptide-1 receptor antagonists
AU2023320411A1 (en) Glucagon-like peptide-1 receptor antagonists
WO2022223007A1 (zh) 抗病毒多肽化合物
JP2005510469A5 (https=)
JPWO2008050830A1 (ja) 抗ｈｉｖ剤
WO2012139519A1 (zh) 环肽及其医药用途
WO2025137159A1 (en) Human interleukin (il)-17 cytokine binding peptides
CN121219305A (zh) Ptp1b/nck1相互作用的抑制剂及其制备和使用方法
HK1227702A1 (en) Novel polypeptides